Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05676203
Title A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients (ARASAFE)
Acronym ARASAFE
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Jena University Hospital
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.